Announcement on Adjustment of Key Technical Personnel
Filed with SSE · · 4 pages · Chinese
Chengdu Olymvax Biopharmaceuticals Inc. on 6ix
Earlier from Chengdu Olymvax Biopharmaceuticals
- Announcement on Resolutions of the 14th Meeting of the 6th Board of Supervisors
- Announcement on Dilution of Immediate Return by Issuing A Shares to Specific Objects with Summary Procedures, Remedial Measures and Commitments of Relevant Entities (Revised Edition)
- Announcement on Release of Pledge of Some Shares Held by Shareholders with Over 5% Shares
- Indicative Announcement on Postponing Term Change of Board of Directors and Board of Supervisors and Expiration of Term of Independent Director
- Announcement on Attending the Annual Collective Performance Briefing for Innovative Drug Companies on SSE STAR Market 2024 and the Q1 2025 Performance Briefing
Later from Chengdu Olymvax Biopharmaceuticals
- Indicative Announcement on Disclosure for Issuing RMB Common Shares (A-shares) to Specific Targets through Simplified Procedures (2nd Revised Draft)
- Announcement on Abnormal Fluctuations in Stock Trading
- 2025 Semi-annual Report
- Announcement on Resolutions of the 4th Meeting of the 7th Board of Directors
- Announcement on Shareholding Reduction Plan for Senior Management Members
Follow Chengdu Olymvax Biopharmaceuticals into a list and get an email when it puts out news.
Follow Chengdu Olymvax Biopharmaceuticals